Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 4/2011

01.08.2011 | Clinical Investigation

Transcatheter Infusion of Epirubicin in Water-in-Oil-in-Water Emulsion via a Cystic Artery for the Treatment of Hepatocellular Carcinoma

verfasst von: I. Ikushima, S. Higashi, A. Ishii, K. Seguchi, Y. Iryo, Y. Ota, M. Shima

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We have previously reported the clinical efficacy of water-in-oil-in-water (W/O/W) emulsion containing anticancer agent. The purpose of this study was to evaluate the safety and effectiveness of transcatheter arterial infusion (TAI) of W/O/W emulsion via a cystic artery for hepatocellular carcinoma (HCC).

Methods

TAI of a W/O/W emulsion was performed at our institute in five patients with Stage III or IV HCC with blood supply from the cystic artery. In all patients, 2–12 ml W/O/W emulsion was infused via a cystic artery. Therapeutic effects and complications were evaluated in these patients.

Results

Of the five patients treated, one achieved a complete response and two achieved a partial response. After treatment, acute cholecystitis or gallbladder ischemia that required treatment was not encountered in any patient.

Conclusions

W/O/W emulsion can be safely infused via a cystic artery without major complications; it is a good therapeutic option for the patients with advanced HCC fed by a cystic artery.
Literatur
1.
Zurück zum Zitat Higashi S, Shimizu M, Nakashima T et al (1995) Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique. Cancer 75:1245–1254PubMedCrossRef Higashi S, Shimizu M, Nakashima T et al (1995) Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique. Cancer 75:1245–1254PubMedCrossRef
2.
Zurück zum Zitat Higashi S, Maeda Y, Kai M et al (1996) A case of hepatocellular carcinoma effectively treated with epirubicin aqueous vesicles in monodispersed iodized poppy-seed oil microdroplets. Hepatogastroenterology 43:1427–1430PubMed Higashi S, Maeda Y, Kai M et al (1996) A case of hepatocellular carcinoma effectively treated with epirubicin aqueous vesicles in monodispersed iodized poppy-seed oil microdroplets. Hepatogastroenterology 43:1427–1430PubMed
3.
Zurück zum Zitat Higashi S, Tabata N, Kondo KH et al (1999) Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water in- oil-in-water emulsion to hepatocellular carcinoma. J Pharmacol Exp Ther 289:816–819PubMed Higashi S, Tabata N, Kondo KH et al (1999) Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water in- oil-in-water emulsion to hepatocellular carcinoma. J Pharmacol Exp Ther 289:816–819PubMed
4.
Zurück zum Zitat Higashi S, Setoguchi T (2000) Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsification technique. Adv Drug Deliv Rev 45:57–64PubMedCrossRef Higashi S, Setoguchi T (2000) Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsification technique. Adv Drug Deliv Rev 45:57–64PubMedCrossRef
5.
Zurück zum Zitat Ikushima I, Higashi S, Seguchi K et al (2009) Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Eur J Radiol 69:114–119PubMedCrossRef Ikushima I, Higashi S, Seguchi K et al (2009) Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Eur J Radiol 69:114–119PubMedCrossRef
6.
Zurück zum Zitat Miyayama S, Matsui O, Nishida H et al (2003) Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol 14:1155–1161PubMed Miyayama S, Matsui O, Nishida H et al (2003) Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol 14:1155–1161PubMed
7.
Zurück zum Zitat Duffaud F, Therasse P (2000) New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer 87:881–886PubMed Duffaud F, Therasse P (2000) New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer 87:881–886PubMed
8.
Zurück zum Zitat Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181PubMedCrossRef
9.
Zurück zum Zitat Kuroda C, Iwasaki M, Tanaka T et al (1983) Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study. Radiology 149:85–89PubMed Kuroda C, Iwasaki M, Tanaka T et al (1983) Gallbladder infarction following hepatic transcatheter arterial embolization. Angiographic study. Radiology 149:85–89PubMed
10.
Zurück zum Zitat Nakamura H, Kondoh H (1986) Emphysematous cholecystitis: complication of hepatic artery embolization. Cardiovasc Intervent Radiol 9:152–153PubMedCrossRef Nakamura H, Kondoh H (1986) Emphysematous cholecystitis: complication of hepatic artery embolization. Cardiovasc Intervent Radiol 9:152–153PubMedCrossRef
11.
Zurück zum Zitat Simons RK, Sinanan MN, Coldwell DM (1992) Gangrenous cholecystitis as a complication of hepatic artery embolization: case report. Surgery 112:106–110PubMed Simons RK, Sinanan MN, Coldwell DM (1992) Gangrenous cholecystitis as a complication of hepatic artery embolization: case report. Surgery 112:106–110PubMed
12.
Zurück zum Zitat Takayasu K, Moriyama N, Muramatsu Y et al (1985) Gallbladder infarction after hepatic artery embolization. AJR Am J Roentgenol 144:135–138PubMed Takayasu K, Moriyama N, Muramatsu Y et al (1985) Gallbladder infarction after hepatic artery embolization. AJR Am J Roentgenol 144:135–138PubMed
13.
Zurück zum Zitat Sakamoto I, Aso N, Nagaoki K et al (1998) Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18:605–619PubMed Sakamoto I, Aso N, Nagaoki K et al (1998) Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18:605–619PubMed
14.
Zurück zum Zitat Hirota S, Matsumoto S, Fukuda T et al (1999) Solitary hepatocellular carcinoma fed by the cystic artery: limitation of transcatheter arterial embolization. Cardiovasc Intervent Radiol 22:206–209PubMedCrossRef Hirota S, Matsumoto S, Fukuda T et al (1999) Solitary hepatocellular carcinoma fed by the cystic artery: limitation of transcatheter arterial embolization. Cardiovasc Intervent Radiol 22:206–209PubMedCrossRef
15.
Zurück zum Zitat Chopra S, Dodd GD III, Chanin MP, Chintapalli KN (2003) Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. Am J Roentgenol 180:697–701 Chopra S, Dodd GD III, Chanin MP, Chintapalli KN (2003) Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. Am J Roentgenol 180:697–701
16.
Zurück zum Zitat Sartori S, Tombesi P, Macario F et al (2008) Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 248:670–679PubMedCrossRef Sartori S, Tombesi P, Macario F et al (2008) Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 248:670–679PubMedCrossRef
17.
Zurück zum Zitat Kim SW, Rhim H, Park M et al (2009) Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol 10:366–376PubMedCrossRef Kim SW, Rhim H, Park M et al (2009) Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol 10:366–376PubMedCrossRef
18.
Zurück zum Zitat Livraghi T, Goldberg SN, Lazzaroni S et al (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661PubMed Livraghi T, Goldberg SN, Lazzaroni S et al (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661PubMed
19.
Zurück zum Zitat Akahane M, Koga H, Kato NY et al (2005) Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics 25(Suppl 1):S57–S68PubMedCrossRef Akahane M, Koga H, Kato NY et al (2005) Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics 25(Suppl 1):S57–S68PubMedCrossRef
20.
Zurück zum Zitat Llovet JM, Vilana R, Brú C et al (2000) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129CrossRef Llovet JM, Vilana R, Brú C et al (2000) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129CrossRef
21.
Zurück zum Zitat Imamura J, Tateishi R, Shiina S et al (2008) Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 103:3057–3062PubMedCrossRef Imamura J, Tateishi R, Shiina S et al (2008) Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am J Gastroenterol 103:3057–3062PubMedCrossRef
Metadaten
Titel
Transcatheter Infusion of Epirubicin in Water-in-Oil-in-Water Emulsion via a Cystic Artery for the Treatment of Hepatocellular Carcinoma
verfasst von
I. Ikushima
S. Higashi
A. Ishii
K. Seguchi
Y. Iryo
Y. Ota
M. Shima
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 4/2011
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-010-9988-6

Weitere Artikel der Ausgabe 4/2011

CardioVascular and Interventional Radiology 4/2011 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.